Mesenchymal Stem Cell Expansion on Defined Peptide Surfaces

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for expanding mesenchymal stem cells (MSCs) in culture require serum and extracellular matrix proteins, which are undefined and costly, introducing variability and limiting their therapeutic applications.

Innovation Solution

MSCs are expanded in serum-free media on a modified culture surface without a feeder cell layer or cell adhesive coating, using surfaces with specific nitrogen and oxygen compositions and plasma-treated materials like polystyrene, allowing for efficient expansion and differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If serum and extracellular matrix proteins are used in culture media and surface coatings, then MSC expansion is supported, but cost increases and variability is introduced

Engineering Contradiction:
ImproveMSC expansion consistencyVSAvoidculture process complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent removes serum and extracellular matrix proteins from the culture system, replacing them with a defined synthetic peptide coating (e.g., RGD peptide) on the culture surface. This extraction of undefined components eliminates batch-to-batch variability while maintaining MSC attachment and expansion capabilities, directly resolving the contradiction between reliability and ease of manufacture.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical parameters of the culture surface by using a defined synthetic peptide coating with specific amino acid sequences (e.g., Arg-Gly-Asp or RGD motif) instead of proteinaceous coatings. This parameter change from complex biological materials to defined synthetic peptides maintains cell adhesion functionality while eliminating variability associated with serum and matrix protein batches.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If feeder cell layers are used to support MSC growth, then cell expansion is enhanced, but process complexity and cost increase

Engineering Contradiction:
ImproveMSC expansion rateVSAvoidculture system structure
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent eliminates the feeder cell layer component from the culture system, replacing the biological support function with a chemically defined synthetic peptide coating on the culture surface. This removal of the feeder layer simplifies the culture system structure while maintaining MSC expansion capability through direct cell-surface interaction mediated by the RGD peptide coating.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention substitutes the mechanical/biological support function of feeder cells with a chemical interaction between the synthetic peptide coating and MSC surface receptors. This replacement of a complex biological system (feeder cells) with a simplified chemical system (peptide coating) reduces process complexity while maintaining productivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If undefined cell culture reagents are used, then MSC growth is supported, but therapeutic application suitability is limited

Engineering Contradiction:
Improvecell therapy product qualityVSAvoidculture media composition
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent removes undefined cell culture reagents (serum, extracellular matrix proteins) from the culture system and replaces them with defined synthetic components. This extraction of undefined substances eliminates potential contaminants and variability sources, making the culture system suitable for therapeutic-grade cell production while maintaining adequate MSC growth support.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses a composite approach by combining a synthetic peptide coating (e.g., RGD sequence) with defined cell culture media components. This composite system replaces complex biological materials with well-characterized synthetic components, ensuring defined composition suitable for therapeutic applications while maintaining MSC expansion capability.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of large numbers of viable, pluripotent MSCs using defined reagents, improving scalability and reducing costs while maintaining pluripotency and differentiation capabilities.

Implementation Method 1

the surface is modified using a plasma treatment

Methodology Applied
Scientific EffectPlasma treatment: Plasma

Data Source

PatentUS20240376434A1Cell expansion methods and compositions for use therein
Publication Date: 2024.11.14 NUNC
  • US20240376434A1 patent drawing
  • US20240376434A1 patent drawing
  • US20240376434A1 patent drawing

AI summary

The instant technology generally relates to methods and compositions for expansion of mesenchymal stem cells in culture on a modified surface in the absence of a cell feeder layer and the absence of a cell adhesive coating on the surface. In some instances, the mesenchymal stem cells are expanded on the modified surface in a serum-free culture medium.